KR101135147B1 - ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid - Google Patents

ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid Download PDF

Info

Publication number
KR101135147B1
KR101135147B1 KR1020090072790A KR20090072790A KR101135147B1 KR 101135147 B1 KR101135147 B1 KR 101135147B1 KR 1020090072790 A KR1020090072790 A KR 1020090072790A KR 20090072790 A KR20090072790 A KR 20090072790A KR 101135147 B1 KR101135147 B1 KR 101135147B1
Authority
KR
South Korea
Prior art keywords
acne
ala
cosmetic composition
aminolevulinic acid
skin
Prior art date
Application number
KR1020090072790A
Other languages
Korean (ko)
Other versions
KR20110015195A (en
Inventor
서정훈
Original Assignee
글로엔엠(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글로엔엠(주) filed Critical 글로엔엠(주)
Priority to KR1020090072790A priority Critical patent/KR101135147B1/en
Publication of KR20110015195A publication Critical patent/KR20110015195A/en
Application granted granted Critical
Publication of KR101135147B1 publication Critical patent/KR101135147B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Abstract

본 발명은 광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 광 민감성 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)와 정제수 및 친수성용매 및 습윤제를 함유하고 있는 화장료 조성물의 보존 및 유효성분의 안정성을 높여 여드름을 효과적으로 치료하며 피부결 개선, 피부트러블 완화 등의 효과를 증대하며 사용자가 용이하도록 사용할 수 있는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing 5-aminolevulinic acid (ALA), a purified water, a hydrophilic solvent, and a humectant, which are photosensitive substances used in PDT (Photo dynamic therapy) for treating acne with light. The present invention relates to a cosmetic composition for treating acne containing 5-aminolevulinic acid that can be easily used by the user by increasing the effects of preserving and improving the stability of the active ingredient, effectively treating acne, improving skin texture, relieving skin troubles, and the like. .

여드름, PDT(Photo dynamic therapy), 5-아미노레불린산(5-Aminolevulinic acid, ALA), Rg2 Acne, PDT (Photo dynamic therapy), 5-Aminolevulinic acid (ALA), Rg2

Description

5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물{ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid}Cosmetic composition for the treatment of acne containing 5-aminolevulinic acid {ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid}

본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로, 광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)와 정제수 및 친수성용매 및 습윤제를 함유하고 있는 화장료 조성물에 있어서, 인삼 사포닌 Rg2를 함유하고 있는 것으로, 화장료 조성물의 보존 및 유효성분의 안정성을 높여 여드름을 효과적으로 치료하며 피부결 개선, 피부트러블 완화 등의 효과를 증대하며 사용자가 용이하도록 사용할 수 있는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물에 관한 것이다.The present invention has been made to solve the above problems, 5-aminolevulinic acid (ALA) and purified water and hydrophilic material which is used for PDT (Photo dynamic therapy) to treat acne by light A cosmetic composition containing a solvent and a humectant, which contains ginseng saponin Rg2, improves the preservation of the cosmetic composition and the stability of the active ingredient, effectively treats acne, and improves skin texture and skin trouble relief. It relates to a cosmetic composition for treating acne containing 5-aminolevulinic acid that can be easily used by a user.

여드름의 호르몬의 작용, 과도한 피지 분비, 세균의 감염 등으로 인한 모피지선, 모낭 및 주변 조직의 염증성 질환이다.It is an inflammatory disease of fur glands, hair follicles and surrounding tissue due to the action of hormones of acne, excessive sebum secretion, bacterial infections.

여드름의 발생은 사춘기가 되면 남녀 모두 호르몬 분비가 왕성해져 피지선을 자극하게 되고 그 피지선이 커져 과도한 피지가 분비하게 된다.Acne is a puberty in both men and women hormonal secretion is active and stimulate the sebaceous gland, the sebaceous gland is enlarged, excessive sebum is secreted.

이와 동시에 모공 입구의 각질층이 두꺼워지고 접착력이 높아져 모공이 좁아지거나 막히게 되어 모낭 내에 과도 분비한 피지가 쌓이게 되고 모낭 내에 살고 있 는 여드름균(Propionibacterium acne, 프로피오니박테리움 애크니)가 번식하여 염증으로 발전하면서 여드름이 발생한다.At the same time, the stratum corneum at the inlet of the pores becomes thicker and the adhesion increases, which causes the pores to narrow or become clogged, causing excessive secretion of sebum in the hair follicles, and the acne bacteria living in the hair follicles (Propionibacterium acne) Acne develops as it develops.

여드름의 치료는 과도한 피지 생성을 억제시키거나 모낭 내 피부세포의 탈락을 정상화하거나 여드름균의 번식을 억제함으로써 가능하다.Treatment of acne is possible by inhibiting excessive sebum production, normalizing the loss of skin cells in the hair follicles or inhibiting the growth of acne bacteria.

이를 위하여 국소 치료 연고를 도포하거나 박피술, 약물복용시술 등의 치료가 이루어지고 있는데, 최근 여드름이 발병하면 햇빛을 받으면 그 증상이 완화된다는 사실이 알려지면서 여드름 치료에 있어서 광선을 도입한 여드름 치료가 이루어지고 있다.To this end, topical therapeutic ointments, dermabrasions, and medications are being treated. Recently, acne has become known to alleviate its symptoms when the sun is exposed to acne. ought.

여드름이 빛을 받으면 그 증상이 완화되는 이유는 여드름의 주 원인균인 여드름균이 생성한 포르피린(Coproporphyrin Ⅲ)이빛을 흡수하면서 활성 산소가 만들어지고, 이것이 여드름균을 파괴하여 여드름의 증상이 완화되는 것이다.When acne gets light, the symptoms are alleviated because porphyrin (Coproporphyrin III) produced by acne bacteria, the main cause of acne, absorbs light and creates free radicals, which destroys acne bacteria and alleviates the symptoms of acne. .

하지만 여드름이 만들어내는 포르피린의 양이 적어 이를 단독 치료만으로 충분한 효과를 거두기 어렵기 때문에 외부에서 포르피린과 유사한 물질을 여드름이 발생한 피부에 도포하여 이를 흡수시키고 광선을 쏘여 줌으로써 피지선과 여드름균을 파괴하는 PDT(Photo Dynamic Therapy) 치료요법이 도입하여 여드름 치료에 사용하고 있다.However, the amount of porphyrin produced by acne is so small that it is difficult to achieve a sufficient effect by treatment alone. PDT, which destroys sebaceous glands and acne bacteria by externally applying a porphyrin-like substance to the skin where acne has occurred, absorbing it and stinging rays (Photo Dynamic Therapy) Therapies have been introduced and used to treat acne.

상기 PDT치료에 사용되고 있는 포르피린 전구체(Precursor)가 5-아미노레불린산(5-Aminolevulinic acid, 이하 "ALA"라 함)이고, 현재 많은 PDT 치료에 사용되고 있다.The porphyrin precursor (Precursor) used in the PDT treatment is 5-aminolevulinic acid (hereinafter referred to as "ALA"), and is currently used in many PDT treatments.

ALA를 이용한 PDT 치료는 자외선 각화증, 건선, 사마귀 및 피부암 등의 피부 질환에 사용되고 있으며, 피부암 또는 기타 병적인 상태에서 비교적 선택적으로 흡수되므로 주변의 정상 조직에는 거의 해를 비추지 않는다.PDT treatment with ALA is used for skin diseases such as ultraviolet keratosis, psoriasis, warts and skin cancer, and is relatively selective in the cancer of the skin or other pathological conditions and thus does little harm to the surrounding normal tissues.

하지만 ALA의 조성문제로 인하여 피부 부작용 또는 과민반응이 발생하고 있다는 문제점이 있다.However, there is a problem that skin side effects or hypersensitivity occurs due to the composition problem of ALA.

한편 ALA를 이용한 액상제형의 화장료 조성물을 개발하여 제조하고 있지만 기술 부족으로 인하여 유통 중 ALA가 분해되어 ALA본연의 기능적인 효과가 떨어지는 문제점이 발생하고 있다.On the other hand, while developing and manufacturing a liquid formulation of the cosmetic composition using ALA, there is a problem that ALA is degraded during distribution due to lack of technology and the functional effect of ALA is inferior.

또한, 기존 수입되는 제품 중 ALA의 안정화 기술부족으로 인하여 분말 원료를 용기에 담아 사용자들에게 희석하여 사용하도록 용기를 적용한 제품을 출시하고 있지만 사용자의 불편을 초래하고 있는 실정이다.In addition, due to the lack of ALA stabilization technology among the existing imported products to market the product is applied to the container to be used to dilute the powder raw material in the container for users, but the situation is causing inconvenience to the user.

본 발명은 광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 광 민감성 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)와 정제수 및 친수성용매 및 습윤제를 함유하고 있는 화장료 조성물의 보존 및 유효성분의 안정성을 높여 여드름을 효과적으로 치료하며 피부결 개선, 피부트러블 완화 등의 효과를 증대하며 사용자가 용이하도록 사용할 수 있는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention relates to a cosmetic composition containing 5-aminolevulinic acid (ALA), a purified water, a hydrophilic solvent, and a humectant, which are photosensitive substances used in PDT (Photo dynamic therapy) for treating acne with light. Providing a cosmetic composition for acne treatment containing 5-aminolevulinic acid that can be easily used by the user by increasing the effect of preserving and improving the stability of the active ingredients, effectively treating acne, improving skin texture, relieving skin troubles, etc. For the purpose of

또한, 5-아미노레불린산(5-Aminolevulinic acid, ALA)의 안정성을 높이며, 치료 중 발생할 수 있는 피부 부작용을 완화할 수 있는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물을 제공하는 것을 목적으로 한다.In addition, to improve the stability of 5-aminolevulinic acid (5-Aminolevulinic acid, ALA), and to provide a cosmetic composition for treating acne containing 5-aminolevulinic acid that can alleviate skin side effects that may occur during treatment For the purpose of

본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로, 광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 광 민감성 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)를 포함하는 화장료 조성물에 있어서, 5-아미노레불린산(5-Aminolevulinic acid, ALA) 1~20 중량%, 정제수 0.1~30 중량%, 인삼 사포닌 Rg2 0.001~20 중량%, 프로필렌글리콜 1~60 중량% 및 에탄올 0.1~30 중량%를 함유하고 있는 것을 특징으로 한다.The present invention has been made to solve the above problems, and includes 5-aminolevulinic acid (ALA), which is a photosensitive material used in PDT (Photo dynamic therapy) for treating acne with light. In the cosmetic composition, 5-aminolevulinic acid (5-Aminolevulinic acid, ALA) 1-20% by weight, purified water 0.1-30% by weight, ginseng saponin Rg2 0.001-20% by weight, propylene glycol 1-60% by weight and It is characterized by containing 0.1 to 30% by weight of ethanol.

삭제delete

또한, 상기 여드름 피부용 화장료 조성물의 제형은 광선으로 여드름을 치료하는 것으로 유연 화장수, 로션, 크림 중에서 선택된 어느 하나인 것을 특징으로 한다.In addition, the formulation of the cosmetic composition for acne skin is characterized in that any one selected from the flexible lotion, lotion, cream to treat acne by light.

본 발명은 광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 광 민감성 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)와 친수성용매 및 습윤제를 함유하고 있는 화장료 조성물의 보존 및 유효성분의 안정성을 높여 여드름 치료에 효과적으로 사용할 수 있다는 효과가 있다.The present invention relates to the preservation of cosmetic compositions containing 5-aminolevulinic acid (ALA), a hydrophilic solvent and a humectant, which are photosensitive substances used in PDT (Photo dynamic therapy) for treating acne with light. By increasing the stability of the active ingredient can be effectively used to treat acne.

또한, 5-아미노레불린산(5-Aminolevulinic acid, ALA)의 안정성을 높임으로써 이를 함유하고 있는 여드름 치료용 화장료 조성물로 인한 피부 부작용을 예방할 수 있으며 피부결 개선에 효과적인 여드름 치료용 화장료 조성물을 제공할 수 있다는 효과가 있다.In addition, by improving the stability of 5-aminolevulinic acid (5-Aminolevulinic acid, ALA) it is possible to prevent skin side effects due to the cosmetic composition for treating acne containing it and provides a cosmetic composition for treating acne effective for improving skin texture The effect is that you can.

이하, 본 발명의 실시예에 따라 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물에 대해 상세히 설명한다.Hereinafter, a cosmetic composition for treating acne containing 5-aminolevulinic acid according to an embodiment of the present invention will be described in detail.

본 발명의 실시예에 따른 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물은 광 민감성 물질인 ALA(5-Aminolevulinic acid)와 정제수, 친수성 용매 및 습윤제를 함유하고 있는 화장료 조성물에 있어서, 인삼 사포닌 Rg2를 함유하고 있는 화장료 조성물에 관한 것이다.The cosmetic composition for treating acne containing 5-aminolevulinic acid according to an embodiment of the present invention is a cosmetic composition containing a 5-Aminolevulinic acid (ALA), purified water, a hydrophilic solvent, and a humectant, which is a light-sensitive substance. A cosmetic composition containing saponin Rg2.

5-아미노레불르산(5-Aminolevulinic acid; 이하 ALA)는 효과에 비해 그 조성 문제로 인하여 여드름의 PDT(Photo dynamic therapy)치료시 피부 부작용이 발생할 수 있으며, 조성물의 안정화가 불안정하여 사용자로 하여금 많은 불편함이 있다.5-Aminolevulinic acid (ALA) is a side effect of acne due to its compositional problems compared to the effect of PDT (Photo dynamic therapy) treatment of acne, and stabilization of the composition is unstable to the user There is discomfort.

상기 ALA 조성물에 인삼 사포닌 Rg2를 첨가함으로써 ALA 화장료 조성물의 PDT 치료서 피부 부작용을 예방하여 완화하며 피부결 개선 및 ALA의 안정화에도 도움을 줄 수 있도록 한다.By adding ginseng saponin Rg2 to the ALA composition, PDT treatment of the ALA cosmetic composition prevents and alleviates skin side effects, and helps to improve skin texture and stabilize ALA.

인삼 사포닌 Rg2는 인삼 사포닌의 한 종류로서 특히 백삼보다 홍삼에 다량으로 함유되어 있다.Ginseng saponin Rg2 is a kind of ginseng saponin, which is contained in red ginseng more than white ginseng.

인삼의 주요 유효성분인 진세노사이드 즉 사포닌은 30여 종의 사포닌 성분이 인삼에 포함되어 있으며 이러한 사포닌 성분들은 각각 다양한 약효를 나타내며 그 구조에 따라 약효의 종류와 강도가 다르게 나타난다.Ginsenoside, the main active ingredient of ginseng, saponin, contains about 30 kinds of saponins in ginseng. Each of these saponins exhibits various effects and their types and strengths vary depending on the structure.

인삼 사포닌의 효능을 간단히 살펴보면 당뇨병 예방, 조혈작용, 뇌기능 강화, 간장보호작용, 항암작용, 중금속 해독작용, 면역력 증가, 성인병 예방, 주름 과 피부 탄력을 개선하며, 노화방지, 여드름과 피부질환의 치유, 피부 보습 등에 효과가 있다.The ginseng saponin can be briefly reviewed for the prevention of diabetes, hematopoiesis, enhancement of brain function, hepatoprotective action, anticancer activity, heavy metal detoxification, increased immunity, prevention of geriatric diseases, improvement of wrinkles and skin elasticity, anti-aging, acne and skin diseases. It is effective for healing and moisturizing the skin.

상기와 같은 작용을 하는 인삼 사포닌 중 Rg2는 자외선이나 스트레스 또는 환경오염등의 유해환경으로부터 피부 항상성을 유지하며 콜라겐 합성을 촉진함으로써 주름 생성을 억제 및 완화함으로써 노화를 방지하여 주름과 탄력 및 피부보습에 효과적이며, 흡수력이 뛰어나고 피부에 자극을 주지 않으며 안정된 효능으로 오랜 시간 동안 피부에 효과를 지속하도록 한다.Of ginseng saponins, Rg2 maintains skin homeostasis from harmful environment such as ultraviolet rays, stress, or environmental pollution, and promotes collagen synthesis to prevent and reduce wrinkles by preventing wrinkles. It is effective, absorbs well, does not irritate the skin, and maintains the effect on the skin for a long time with a stable effect.

또한 여드름과 피부질환 및 피부과 시술에 의한 피부 부작용을 완화하며 개 선하는 효과가 있다.In addition, it has the effect of reducing and improving the side effects of acne and skin diseases and dermatological procedures.

특히 피지가 많이 생성되며 각질층이 두껍고 모공이 크고 거친 피부결을 가지고 있는 여드름 피부를 상기 인삼 사포닌 Rg2가 피부에 보습과 탄력을 제공함으로써 피부결을 개선하며, 시술 부작용으로 인한 피부에 자극을 주지 않고 빠른 시간 내에 원래의 피부로 돌아갈 수 있도록 한다.In particular, acne skin with a lot of sebum, thick stratum corneum, large pores and rough skin texture, ginseng saponin Rg2 improves the skin texture by providing moisture and elasticity to the skin, without causing irritation to the skin due to side effects of the procedure Allow time to return to your original skin.

본 발명에서는 상기 인삼 사포닌 Rg2는 통상적으로 추출하는 방법인 홍삼 사포닌 성분 중 Re만을 추출하여 이를 분리 정제한 것을 다시 산 가수분해 하여 추출된 것을 사용했다.In the present invention, the ginseng saponin Rg2 was extracted by acid hydrolysis of the red ginseng saponin component, which is a method of extracting the red ginseng saponin, which is separated and purified.

ALA가 함유되어 있는 화장료 조성물에 인삼 사포닌 Rg2를 첨가하여 함유하는 여드름 치료용 화장료 조성물은 ALA 1~20 중량%, 정제수 0.1~30 중량%, Rg2 0.001~20 중량%, 프로필렌글리콜 1~60 중량%, 에탄올 0.1~30 중량%를 포함하여 구성된다. The cosmetic composition for acne treatment containing ginseng saponin Rg2 added to the cosmetic composition containing ALA contains 1 to 20 wt% of ALA, 0.1 to 30 wt% of purified water, 0.001 to 20 wt% of Rg2, and 1 to 60 wt% of propylene glycol. It comprises 0.1 to 30% by weight of ethanol.

상기 ALA는 분말 또는 액체 타입으로 첨가될 수 있는데, 최종 조성되는 화장료 조성물의 ALA의 안정성 및 보존성을 높일 수 있도록 분말형태로 이루어진 것을 사용하는 것이 바람직하다.The ALA may be added in the form of a powder or a liquid, and it is preferable to use the powder in the form of a powder to increase the stability and preservation of the ALA of the final cosmetic composition.

상기의 조성물로 이루어진 여드름 치료용 화장료 조성물은 정제수와, 프로필린글리콜의 첨가량을 조절함으로써 화장료 조성물의 제형을 유연 화장수, 로션, 크림 중 선택하여 제조할 수 있다.The cosmetic composition for treating acne consisting of the above composition can be prepared by adjusting the amount of purified water and propyllin glycol, and selecting the formulation of the cosmetic composition from a flexible lotion, lotion, cream.

상기 첨가되는 조성물 중 프로필렌글리콜은 화장료 조성물이 외부환경요인으로 제형이 변하거나 분해되는 것을 방지하여 화장료 조성물의 안정성을 유지하며, 항균작용 및 박테리아의 생장을 억제하는 효과가 있으며 습윤제 및 수분제, 방부제의 역할을 하여 크림류, 로션, 연고제 등에 사용된다.Propylene glycol of the added composition prevents the cosmetic composition from changing or degrading the formulation due to external environmental factors to maintain the stability of the cosmetic composition, and has the effect of inhibiting the antibacterial action and growth of bacteria, wetting agents, moisture agents, preservatives Used in creams, lotions and ointments.

상기 ALA 조성물이 함유되어 있는 화장료의 조성물의 안정성과 피부결 개선 및 시술에 대하여 발생되는 피부 부작용 완화에 있어서, 인삼 사포닌 Rg2와 프로필렌글리콜이 상호 보완작용을 함으로써 ALA 화장료 조성물의 보존 및 유효성분의 안정성을 높여 여드름을 효과적으로 치료할 수 있도록 한다.In stabilizing the composition of the cosmetic composition containing the ALA composition and improving skin texture and alleviating skin side effects caused by the procedure, ginseng saponin Rg2 and propylene glycol mutually complementary action to preserve the stability of the ALA cosmetic composition and stability of the active ingredient Increase your chances of treating acne effectively.

실시예. 화장료 조성물의 조성.Example. The composition of the cosmetic composition.

자석 교반기에 정제수 130g,에탄올 109g, Rg2 2g, 프로필렌글리콜 600g을 첨가하여 잘 혼합한 뒤 분말 ALA 150g을 천천히 교반하면서 투입, 녹임으로써 ALA의 농도가 15%이며 약간의 점성이 있는 연노랑의 투명한 로션제형의 화장료 조성물을 제조한다.130g of purified water, 109g of ethanol, 2g of Rg2, and 600g of propylene glycol were added to the magnetic stirrer, and the mixture was mixed well. 150g of powder ALA was slowly added to the solution and dissolved. The cosmetic composition is prepared.

실험. UV 스펙트럼을 이용한 ALA 잔량측정Experiment. Residual ALA Measurement Using UV Spectrum

상기 실시예에 따라 조성된 화장료 조성물을 제조했을 당시의 UV 스펙트럼을 이용하여 ALA의 잔량과 2개월 후의 ALA의 잔량을 조사하여 도 1에 도시하였다.The residual amount of ALA and the residual amount of ALA after 2 months were investigated using the UV spectrum at the time of preparing the cosmetic composition prepared according to the above embodiment, and are shown in FIG. 1.

이와 비교하기 위하여 실험 대조군으로 자석 교반기에 정제수 252g, 에탄올 400g을 첨가하여 잘 혼합한 뒤 분말 ALA 75g을 천천히 교반하면서 투입, 녹임으로써 ALA의 농도가 7.5%인 액상형의 조성물을 제조한 당시의 UV 스펙트럼을 이용하여 ALA의 잔량과 개봉 후 2개월 후의 ALA의 잔량을 조사하여 도 2에 도시하였다.For comparison, UV spectra at the time of preparing a liquid composition having a concentration of 7.5% of ALA by adding and melting 252 g of purified water and 400 g of ethanol to a magnetic stirrer as an experimental control, mixing and melting 75 g of powder ALA while stirring slowly. The residual amount of ALA and the residual amount of ALA two months after opening were examined using FIG.

도 1에 도시된 바와 같이 본 발명의 실시예에 따라 조성된 화장료 조성물의 조성된 당시의 농도가 15%인 ALA가 2개월의 시간이 흐를 경우 ALA의 농도가 대략적 으로 14.8%로 조사되어 ALA가 거의 분해되지 않는 걸 알 수 있다.As shown in FIG. 1, when the ALA having a concentration of 15% at the time of composition of the cosmetic composition prepared according to the embodiment of the present invention passes over a period of two months, the concentration of ALA is approximately 14.8% and thus ALA is You can see that it hardly decomposes.

이와는 반대로 도2에 도시된 바와 같이, ALA에 친수성 용매 등으로 조성된 조성물인 경우 개봉전 ALA농도가 7.5%를 나타내고 있지만 2개월 후의 ALA의 농도는 ALA가 생분해되어 검출이 안된다는 것을 알 수 있다.On the contrary, as shown in FIG. 2, in the case of a composition composed of a hydrophilic solvent or the like in ALA, the concentration of ALA before opening was 7.5%, but the concentration of ALA after two months was not detected because ALA was biodegraded.

따라서 ALA의 안정성을 프로필렌글리콜과 인삼 사포닌 Rg2의 피부를 자극하지 않고 보호하며 여드름 등의 피부질환에 효과적이며 우수한 안정성으로 불안정한 ALA의 안정화에 상호보완하여 화장료 조성물의 보존 및 유효성분의 안정성을 높일 수 있다는 것을 알 수 있다.Therefore, it protects the stability of ALA without irritating the skin of propylene glycol and ginseng saponin Rg2, and it is effective for skin diseases such as acne, and it is complementary to stabilization of unstable ALA with excellent stability, which can enhance the preservation of cosmetic composition and the stability of active ingredients. It can be seen that there is.

상기와 같은 실험을 통하여 ALA의 안정성이 우수하다는 것을 알 수 있으며, 화장료 조성물을 PDT 치료에 있어서, 치료시 방사되는 광선에 노출된 피부가 부작용을 일으키지 않고, 피부를 보호하며 광선으로 인한 노화를 방지하며 피부결 개선 등에 효과가 있는 Rg2가 함유되어 있어 여드름 치료와 피부결 개선 및 주름 및 탄력에도 효과가 있다.Through the above experiments, it can be seen that the stability of the ALA is excellent, and in the PDT treatment of the cosmetic composition, the skin exposed to the radiation emitted during the treatment does not cause side effects, protects the skin, and prevents aging due to light rays. It contains Rg2, which is effective in improving skin texture, and is effective in treating acne, improving skin texture, wrinkles and elasticity.

본 발명은 상술한 실시예에만 한정되는 것은 아니고 당업자로서는 본 발명의 사상과 범주를 벗어나지 않는 범위 내에서 다양하게 변형, 변경 및 치환할 수 있다. The present invention is not limited only to the above-described embodiments, and those skilled in the art can variously modify, change, and substitute the present invention without departing from the spirit and scope of the present invention.

도 1은 본 발명의 실시예에 따라 조성된 여드름 치료용 화장료 조성물의 UV 스펙트럼을 이용하여 ALA의 잔량과 2개월 후의 ALA의 잔량을 조사하여 도시한 그래프.1 is a graph showing the residual amount of ALA and the residual amount of ALA after 2 months using the UV spectrum of the cosmetic composition for treating acne according to an embodiment of the present invention.

도 2는 대조군으로 액상형의 ALA 화장료 조성물의 UV 스펙트럼을 이용하여 ALA의 잔량과 2개월 후의 ALA의 잔량을 조사하여 도시한 그래프.Figure 2 is a graph showing the residual amount of ALA and the residual amount of ALA after 2 months using the UV spectrum of the liquid ALA cosmetic composition as a control.

Claims (3)

광선으로 여드름을 치료하는 PDT(Photo dynamic therapy)에 사용되는 광 민감성 물질인 5-아미노레불린산(5-Aminolevulinic acid, ALA)를 포함하는 화장료 조성물에 있어서,In the cosmetic composition comprising 5-aminolevulinic acid (ALA), which is a photosensitive material used in PDT (Photo dynamic therapy) for treating acne with light, 5-아미노레불린산(5-Aminolevulinic acid, ALA) 1~20 중량%, 정제수 0.1~30 중량%, 인삼 사포닌 Rg2 0.001~20 중량%, 프로필렌글리콜 1~60 중량% 및 에탄올 0.1~30 중량%를 함유하고 있는 것을 특징으로 하는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물.1-20% by weight of 5-Aminolevulinic acid (ALA), 0.1-30% by weight of purified water, 0.001-20% by weight of ginseng saponin Rg2, 1-60% by weight of propylene glycol and 0.1-30% by weight of ethanol Cosmetic composition for acne treatment containing 5-aminolevulinic acid, characterized in that it contains. 삭제delete 제1항에 있어서, 상기 여드름 피부용 화장료 조성물의 제형은 광선으로 여드름을 치료하는 것으로 유연 화장수, 로션, 크림 중에서 선택된 어느 하나인 것을 특징으로 하는 5-아미노레불린산을 함유한 여드름 치료용 화장료 조성물.According to claim 1, wherein the formulation of the cosmetic composition for acne skin is to treat acne with a light acne treatment cosmetic composition containing 5-aminolevulinic acid, characterized in that any one selected from flexible lotion, lotion, cream. .
KR1020090072790A 2009-08-07 2009-08-07 ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid KR101135147B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090072790A KR101135147B1 (en) 2009-08-07 2009-08-07 ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090072790A KR101135147B1 (en) 2009-08-07 2009-08-07 ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid

Publications (2)

Publication Number Publication Date
KR20110015195A KR20110015195A (en) 2011-02-15
KR101135147B1 true KR101135147B1 (en) 2012-04-16

Family

ID=43774062

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090072790A KR101135147B1 (en) 2009-08-07 2009-08-07 ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid

Country Status (1)

Country Link
KR (1) KR101135147B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102265592B1 (en) 2020-10-29 2021-06-17 김진왕 Composition containing 5-aminolevulinic acid hydrochloride

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101361899B1 (en) * 2011-05-23 2014-02-12 성균관대학교산학협력단 Method of cosmetic compositions for improving acne
CN103536450B (en) * 2012-07-09 2015-08-05 吉林博大东方生物科技有限公司 Anti-acne external product and effective ingredient preparation method thereof
KR101505446B1 (en) * 2013-05-16 2015-03-25 (주) 위디어 Preparation method of 5-aminolevulinic acid and Use of the same
KR20160101372A (en) 2015-02-17 2016-08-25 제너럴바이오(주) A composition for skin regeneration for application to the skin
KR101654028B1 (en) 2015-02-17 2016-09-05 제너럴바이오(주) Cosmetic composition for application to the skin and manufacturing method for the same
KR101963430B1 (en) 2017-07-03 2019-03-28 제너럴바이오(주) Method for manufacturing methyl 5-bromolevulinate and manufacturing method 5-aminolevulinic acid heyl ester hydrochloride using the same
KR102333954B1 (en) * 2020-07-31 2021-12-02 정직한화장품사업자 협동조합 Cosmetic composition containing 5-aminolevulinic acid
CN115554190A (en) * 2022-10-28 2023-01-03 山东深海生物科技股份有限公司 Moisturizing preparation containing 5-aminolevulinic acid and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040076092A (en) * 2003-02-24 2004-08-31 김정철 Methods for treating acne using ALA with cationic liposome
KR100568601B1 (en) 2004-03-03 2006-04-24 소망화장품주식회사 Cosmetic composition comprising saponin compounds containing ginsenoside Rg2 for protecting skin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040076092A (en) * 2003-02-24 2004-08-31 김정철 Methods for treating acne using ALA with cationic liposome
KR100568601B1 (en) 2004-03-03 2006-04-24 소망화장품주식회사 Cosmetic composition comprising saponin compounds containing ginsenoside Rg2 for protecting skin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102265592B1 (en) 2020-10-29 2021-06-17 김진왕 Composition containing 5-aminolevulinic acid hydrochloride
WO2022092735A1 (en) 2020-10-29 2022-05-05 김진왕 Composition containing 5-aminolevulinic acid hydrochloride

Also Published As

Publication number Publication date
KR20110015195A (en) 2011-02-15

Similar Documents

Publication Publication Date Title
KR101135147B1 (en) ANTI-ACNE COSMETIC COMPOSITION CONTAINING 5-Aminolevulinic acid
CN106580798A (en) All-in-one eye cream and preparation method
US20060013845A1 (en) Oxygenated personal care products
Rathod et al. Cosmeceuticals and Beauty Care Products: Current trends with future prospects
US20110236503A1 (en) Topical Skincare Composition
KR100673044B1 (en) The composition for external use by percutaneous administration
KR20110074513A (en) Topical treatment of skin infection
KR20200113600A (en) Composition for hairloss and scalp care
CN104825347B (en) A kind of medical bio whitening and spot-eliminating dressing and preparation method thereof
US11918666B2 (en) Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment
RU2121341C1 (en) Curative-cosmetic cream
CN108478464A (en) A kind of skin makeup peptide facial mask liquid and preparation method thereof
RU2295951C1 (en) Composition for face and eyelids skin care
EP2238981B1 (en) Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser
Varpe et al. Aloe vera Compositions Used for Medicinal Applications: A Patent Review (2013-till 2020)
KR102293585B1 (en) Wax-type cleanser
KR102420354B1 (en) Lotion composition having circulation and vitality and the manufacturing method thereof
ITLI20110005A1 (en) COMPOSITION FOR THE CARE OF PSORIASIS AND RELATED SKIN DISEASES
AU2021103390A4 (en) A Skincare Oil
KR20100094109A (en) Functional skin lotion including date
EP4085913A1 (en) Formulation comprising nicotinamide, zinc, copper and glutathione for treating acne rosacea
KR102329748B1 (en) Wax-type cleanser improving problematic skin
EP3458019A1 (en) Product for the therapy and prevention of burnout syndrome of the scalp and the skin
Ganpat et al. Formulate and Evaluate Aloe-Vera Face Wash
CN100411627C (en) Desensitization face pack for treating facial dermatitis

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180402

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20180411

Year of fee payment: 9